Literature DB >> 1419480

Alterations in G-protein expression, Gi function and stimulatory receptor-mediated regulation of adipocyte adenylyl cyclase in a model of insulin-resistant diabetes with obesity.

T M Palmer1, P V Taberner, M D Houslay.   

Abstract

The stimulatory effect of Mn2+ (1.5-fold), forskolin (1.6-fold) and low (1 microM) concentrations of GTP (1.9-fold) on the adenylyl cyclase of adipocyte membranes from obese, diabetic CBA/Ca mice was markedly enhanced compared to that seen using membranes prepared from their lean littermates. In contrast, receptor-mediated stimulation, achieved with either isoprenaline or secretin was reduced and that by glucagon abolished in membranes from diabetic animals. The levels of expression of alpha-subunits of Gi-1, Gi-2 and Gi-3 were reduced to some 49, 76 and 54%, respectively, in membranes from diabetic animals compared with those from normal animals. Levels of G-protein beta-subunits and Gs alpha-subunits were similar. Receptor-mediated inhibition of adenylate activity elicited by either nicotinic acid or prostaglandin E1 (PGE1) was of a similar magnitude in membranes from normal and diabetic animals but the inhibitory action of N6-(L-2-phenylisopropyl)adenosine (PIA) was greater in membranes from diabetic animals by about 30%. Gi function was similarly evident in membranes from both lean and diabetic animals, as assessed using low concentrations of guanylyl 5'-imidodiphosphate to inhibit forskolin-stimulated adenylyl cyclase activity. However, assessing Gi function using GTP showed marked dissimilarities in that the elevated GTP concentrations expected to occur physiologically were incapable of reversing the stimulation achieved at low concentrations of GTP in membranes from diabetic but not normal animals. The adipocytes of CBA/Ca mice, as do other animal models of insulin resistance, show lesions in adenylyl cyclase regulation, Gi function and G-protein expression.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1419480     DOI: 10.1016/0898-6568(92)90031-3

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  6 in total

1.  High-glucose incubation of human umbilical-vein endothelial cells does not alter expression and function either of G-protein alpha-subunits or of endothelial NO synthase.

Authors:  G Mancusi; C Hutter; S Baumgartner-Parzer; K Schmidt; W Schütz; V Sexl
Journal:  Biochem J       Date:  1996-04-01       Impact factor: 3.857

2.  Caffeine ingestion does not alter carbohydrate or fat metabolism in human skeletal muscle during exercise.

Authors:  T E Graham; J W Helge; D A MacLean; B Kiens; E A Richter
Journal:  J Physiol       Date:  2000-12-15       Impact factor: 5.182

3.  Competition for Gβγ dimers mediates a specific cross-talk between stimulatory and inhibitory G protein α subunits of the adenylyl cyclase in cardiomyocytes.

Authors:  Hans-Jörg Hippe; Mark Lüdde; Katrin Schnoes; Ana Novakovic; Susanne Lutz; Hugo A Katus; Feraydoon Niroomand; Bernd Nürnberg; Norbert Frey; Thomas Wieland
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-04-26       Impact factor: 3.000

4.  Identification of two splice variant forms of type-IVB cyclic AMP phosphodiesterase, DPD (rPDE-IVB1) and PDE-4 (rPDE-IVB2) in brain: selective localization in membrane and cytosolic compartments and differential expression in various brain regions.

Authors:  M Lobban; Y Shakur; J Beattie; M D Houslay
Journal:  Biochem J       Date:  1994-12-01       Impact factor: 3.857

5.  Analysis of the adenylate cyclase signalling system, and alterations induced by culture with insulin, in a novel SV40-DNA-immortalized hepatocyte cell line (P9 cells).

Authors:  C Livingstone; C MacDonald; B Willett; M D Houslay
Journal:  Biochem J       Date:  1994-06-15       Impact factor: 3.857

Review 6.  A compendium of G-protein-coupled receptors and cyclic nucleotide regulation of adipose tissue metabolism and energy expenditure.

Authors:  Ryan P Ceddia; Sheila Collins
Journal:  Clin Sci (Lond)       Date:  2020-03-13       Impact factor: 6.876

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.